NCT02481284

Brief Summary

The purpose of this study was to perform a quantitative perfusion study of the undermined abdominal skin in deep inferior epigastric artery perforator flap breast reconstruction patients in order to obtain more knowledge on perfusion dynamics. Laser Doppler perfusion imaging (LDPI) was used to evaluate this. Microcirculatory changes were monitored in the abdominal skin of 20 consecutive patients. Measurements were taken and recorded within four standardized zones covering the skin between the xiphoid process and the upper incisional boundary of the flap (zone 1-4; cranial to caudal).

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
20

participants targeted

Target at below P25 for all trials

Timeline
Completed

Started Jan 2008

Longer than P75 for all trials

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

January 1, 2008

Completed
1.7 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

September 1, 2009

Completed
5.5 years until next milestone

Study Completion

Last participant's last visit for all outcomes

March 1, 2015

Completed
2 months until next milestone

First Submitted

Initial submission to the registry

May 11, 2015

Completed
2 months until next milestone

First Posted

Study publicly available on registry

June 25, 2015

Completed
Last Updated

June 25, 2015

Status Verified

June 1, 2015

Enrollment Period

1.7 years

First QC Date

May 11, 2015

Last Update Submit

June 22, 2015

Conditions

Keywords

Breast reconstructionDeep inferior epigastric artery perforator flapSkin perfusionPlastic and reconstructive surgery

Outcome Measures

Primary Outcomes (7)

  • Perfusion of the abdominal zones measured in mean perfusion units

    Preoperative

  • Perfusion of the abdominal zones measured in mean perfusion units

    two hours (After raising the flap)

  • Perfusion of the abdominal zones measured in mean perfusion units

    Three hours (After undermining)

  • Perfusion of the abdominal zones measured in mean perfusion units

    Five hours (After abdominal closure)

  • Perfusion of the abdominal zones measured in mean perfusion units

    Postoperative day 1 (POD1)

  • Perfusion of the abdominal zones measured in mean perfusion units

    Postoperative day 3 (POD3)

  • Perfusion of the abdominal zones measured in mean perfusion units

    Postoperative day 7 (POD7)

Study Arms (1)

Laser Doppler Perfusion Imaging

20 consequetive cases undergoing breast reconstruction with Deep inferior epigastric artery perforator flap who had evaluation of the microcirculation of the abdominal skin with laser Doppler perfusion imaging

Device: Laser Doppler perfusion imaging

Interventions

LDPI is an extension of laser Doppler flowmetry (LDF) and was developed to generate a colour-coded perfusion image in a large area of skin.

Laser Doppler Perfusion Imaging

Eligibility Criteria

Sexfemale
Healthy VolunteersNo
Age GroupsChild (0-17), Adult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

20 women consecutively undergoing secondary, unilateral breast reconstruction with a DIEAP flap were identified and recruited to participate in the study. The patients were informed about of risks and benefits and gave written consent prior to participation. All smokers stopped smoking 4 weeks prior to surgery.

You may qualify if:

  • Secondary, unilateral breast reconstruction with a DIEAP
  • All smokers stopped smoking 4 weeks prior to surgery

You may not qualify if:

  • Metastatic disease
  • Bilateral breast reconstruction

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Department of Plastic and Reconstructive Surgery

Oslo, Oslo County, 0424, Norway

Location

Study Officials

  • Kim A Tønseth, MD, PhD

    Oslo University Hospital

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
observational
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Head of Department

Study Record Dates

First Submitted

May 11, 2015

First Posted

June 25, 2015

Study Start

January 1, 2008

Primary Completion

September 1, 2009

Study Completion

March 1, 2015

Last Updated

June 25, 2015

Record last verified: 2015-06

Locations